Market Overview:

The Coccidiosis Treatment Market is forecasted to reach $3.2 billion by 2030, growing at a CAGR of 3.6% from 2024 to 2030. The growth is attributed to the rising prevalence of coccidian diseases in poultry, swine, and companion animals, combined with the increased adoption of intensive farming techniques across developed countries. Coccidiosis, caused by Coccidia parasites, primarily affects the intestines of birds and mammals, leading to significant economic losses in the poultry and livestock industries.

Regional Insights:

In 2023, North America dominated the Coccidiosis Treatment Market, holding the largest share at 36%, largely due to the region’s extensive poultry farming industry and high demand for meat and poultry products. The U.S. poultry sector alone faces an estimated $300 million in annual losses due to coccidiosis, making prevention and treatment a high priority. The growing awareness of coccidiosis treatment alternatives and improvements in veterinary healthcare across the region further bolster market growth.

For More Queries About " Coccidiosis Treatment " @  https://www.industryarc.com/pdfdownload.php?id=16891

 
Scope of the Report:

Report Metric 

Details 

Base Year Considered

2023

Forecast Period

2024–2030

CAGR

3.6%

Market Size in 2030

$3.2 Billion

Segments Covered

By Drug Type, By Infected Animal Species, and By Region

Geographies Covered

North America (USA, Canada, and Mexico), Europe (UK, Germany, France, Italy, Netherlands, Spain, Russia, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Malaysia, and Rest of APAC), South America (Brazil, Argentina, Colombia, Chile, and Rest of South America), and Rest of the World (Middle East, and Africa).

Key Market Players

1.       dsm-firmenich

2.       Vetoquinol SA

3.       Zoetis, Inc.

4.       Huvepharma

5.       Boehringer Ingelheim Vetmedica, Inc.

6.       Merck Animal Health

7.       HIPRA

8.       Elanco 

9.       Merial

10.   Bayer Animal Health 


Recent Developments:

  •  In June 2023, DSM-Firmenich completed the acquisition of Adare Biome, a leading company in postbiotic solutions. Additionally, in November 2022, DSM-Firmenich acquired Essex, further expanding its portfolio in health and nutrition solutions.Coccidiosis Treatment Market: Competitive LandscapeThe Coccidiosis Treatment market is competitive, with key players focusing on product innovation, strategic partnerships, and geographical expansion. Major companies include: DSM-Firmenich, Vetoquinol SA, Zoetis, Inc., Huvepharma, Boehringer Ingelheim Vetmedica, Inc., Merck Animal Health, HIPRA, Elanco, Merial, and Bayer Animal Health.

About IndustryARC™:

IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets. 
 
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.

Contact Us:

Mr. Venkat Reddy
IndustryARC
USA: (+1) 518-282-4727